Complicated Intra-abdominal Infection
📧 Sign up to get email alerts when something new happens for Complicated Intra-abdominal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: GSK2251052 in the Treatment of Complicated Intra-abdominal Infections [Phase 2]
A Phase 2 trial of GSK2251052 for complicated intra-abdominal infections was terminated, with results posted in 2017.
-
FDA approval · 2017-08-29FDA Approved: VABOMERE — Original Application (Melinta Therapeutics, LLC)
FDA approved VABOMERE (meropenem-vaborbactam) from Melinta Therapeutics as an original application.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED) [Phase 4]
Phase 4 study evaluating ertapenem versus a comparator in adults with complicated intra-abdominal infection has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating an investigational agent for complicated intra-abdominal infections and a…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) [Phase 3]
A Phase 3 randomized trial comparing ertapenem sodium to piperacillin/tazobactam for complicated intra-abdominal infections has completed, s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections [Phase 3]
Phase 3 trial comparing ceftazidime-avibactam plus metronidazole versus meropenem in adults with complicated intra-abdominal infections has …
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections [Phase 3]
Phase 3 trial comparing ceftazidime-avibactam plus metronidazole to meropenem in hospitalized adults with complicated intra-abdominal infect…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens [Phase 3]
Phase 3 trial update for ceftazidime-avibactam in complicated urinary tract infection and complicated intra-abdominal infection has been com…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections [Phase 2]
Phase 2 trial comparing TP-434 with ertapenem for complicated intra-abdominal infection has completed with results posted.
-
FDA label_change · 2015-09-02FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
FDA supplemental application for Avycaz (ceftazidime/avibactam) submitted by Allergan to modify the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections [Phase 2]
A Phase 2 trial comparing intravenous CXA 101/tazobactam with metronidazole and meropenem in complicated intraabdominal infections has compl…
-
FDA approval · 2014-12-19FDA Approved: ZERBAXA — Original Application (Merck Sharp & Dohme LLC)
FDA approved ZERBAXA (ceftolozane and tazobactam) via Original Application for the treatment of complicated intra-abdominal infections and c…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections [Phase 3]
A Phase 3 safety and tolerability trial comparing doripenem with meropenem in children with complicated intra-abdominal infections was termi…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
A completed clinical trial evaluating the safety and effectiveness of doripenem in Filipino patients with nosocomial pneumonia, complicated …
-
CLINICAL_TRIALS withdrawal · 2013-02-22Clinical Trial Update: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia [Phase 3]
A Phase 3 trial comparing tigecycline to ceftriaxone for complicated intra-abdominal infection and community-acquired pneumonia has been wit…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects [Phase 3]
A Phase 3 clinical trial comparing tigecycline to imipenem/cilastatin in hospitalized patients with complicated intra-abdominal infections h…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections
The completed study evaluated how bacterial resistance affects healthcare costs for hospitalized patients with complicated intra-abdominal i…
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating tigecycline versus ceftriaxone for complicated intra-abdominal infections and community-acquired pneumonia has be…
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem [Phase 3]
A Phase 3 trial comparing moxifloxacin to ertapenem for complicated intra-abdominal infections has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections [Phase 3]
Phase 3 trial comparing tigecycline with imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections has completed e…
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI [Phase 4]
A Phase 4 clinical trial evaluating the safety and efficacy of tigecycline for complicated intra-abdominal infection in hospitalized patient…
-
FDA approval · 2008-03-20FDA Approved: CEFEPIME — Original Application (Sagent Pharmaceuticals)
FDA records the original approval of cefepime hydrochloride (cefepime) for Sagent Pharmaceuticals under an ANDA. The approval concerns a bro…
-
FDA label_change · 2007-01-24FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for TYGACIL (tigecycline) submitted by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., to up…